NUS
Nu Skin Enterprises, Inc.
NYSE · Consumer Defensive · Household & Personal Products · US
$4.84
+2.98%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.4B | 1.5B | 1.7B | 2.0B | 2.2B |
| Cost of Revenue | 423.8M | 453.8M | 550.2M | 611.9M | 630.9M |
| Gross Profit | 951.5M | 1.0B | 1.2B | 1.4B | 1.6B |
| Operating Expenses | |||||
| R&D Expense | 10.8M | — | 13.0M | 22.6M | — |
| SG&A Expense | 881.2M | 940.5M | 1.1B | 1.3B | 1.4B |
| General & Admin Expense | 401.6M | 432.1M | 479.0M | 546.9M | 555.8M |
| Selling & Marketing Expense | 479.6M | 508.4M | 652.0M | 742.4M | 879.6M |
| Other Expenses | 68.1M | — | 189.4M | (2.8M) | 48.5M |
| Total Operating Expenses | 960.1M | 940.5M | 1.3B | 1.3B | 1.5B |
| Cost and Expenses | 1.4B | 1.4B | 1.9B | 1.9B | 2.1B |
| Operating Income (EBIT) | (8.6M) | 90.9M | (151.6M) | 48.3M | 110.8M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | 10.4M |
| Interest Expense | 15.7M | 13.9M | 26.4M | 25.6M | 21.9M |
| Net Interest Income | (15.7M) | (13.9M) | (26.4M) | (25.6M) | (11.5M) |
| Other Non-Op Income/Expense | (17.8M) | 105.3M | (23.5M) | (21.7M) | (21.9M) |
| Non-Operating Income (excl Interest) | 2.1M | (119.3M) | (2.9M) | (85.5M) | 8.4M |
| EBT (Pre-Tax Income) | (26.4M) | 196.2M | (175.1M) | 26.6M | 89.0M |
| Income Tax Expense | 190.0M | 36.0M | (28.5M) | 18.0M | (15.8M) |
| Bottom Line | |||||
| Net Income | (216.4M) | 160.2M | (146.6M) | 8.6M | 104.8M |
| Earnings from Cont. Ops | (216.4M) | 160.2M | (146.6M) | 8.6M | 104.8M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (216.4M) | 160.2M | (146.6M) | 8.6M | 104.8M |
| Per Share | |||||
| Basic EPS | ($4.45) | $3.25 | ($2.95) | $0.17 | $2.10 |
| Diluted EPS | ($4.47) | $3.18 | ($2.95) | $0.17 | $2.07 |
| Revenue Per Share | $28.30 | $30.13 | $34.88 | $39.61 | $44.51 |
| Shares | |||||
| Basic Shares Outstanding | 48.6M | 49.3M | 49.7M | 49.7M | 50.0M |
| Diluted Shares Outstanding | 48.6M | 50.3M | 49.7M | 49.9M | 50.5M |
| Profitability Metrics | |||||
| EBITDA | 39.3M | 262.4M | (78.8M) | 203.0M | 175.0M |
| D&A | 50.0M | 52.3M | 69.8M | 69.2M | 72.5M |
| EBIT | (10.7M) | 210.1M | (148.6M) | 133.8M | 102.5M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026